Redirecting to http://dergipark.org.tr/_fragment?_hash=4K9ppwj9vAHN74QBBhti8qxorhvA8zly81mfEUG2qVY&_path=id%3D55760%26_format%3Dhtml%26_locale%3Den%26_controller%3DApp%255CController%255CSite%255CArticleController%253A%253AesiArticleStats.
 
BibTex RIS Cite

Behçet hastalığında sistemik isotretinoin tedavisine bağlı hipertofik skarlar: olgu sunumu

Year 2010, Volume: 32 Issue: 1, 137 - 138, 11.03.2010

Elif Öztürk Melih Akyol , Sedat Özçelik

Abstract

"Abstract" yok

Keywords

-

References

  • Bauer EA. Seltzer JL. Eisen AZ. Inhibition of collagen degradative enzymes by retinoic acid in vitro. J Am Acad Dermatol 1982: 6: 603-7.
  • Bernestein LJ, Geronemus RG. Keloid formation with the 585-nm pulsed dye laser during isotretionin treatment. Arch Dermatol 1997: 133: 111-2.
  • Adam B. Calikoglu E. Serum interleukin-6. procalcitonin and C-reactive protein levels in subjects with active Behçet’s disease. J Eur Acad Dermatol Venereol 2004: 18: 318-20.
  • Xue H. McCauley RL. Zhang W. Elavated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000; 89: 74-7.
  • Akyol M, Doğan S, Kaptanoğlu E, Özçelik S. Systemic isotretinoin in the treatment of a Behçet’s patient with arthritic symptoms and acne lesions. Clin Exp Rheumatol 2002; 20(4 Suppl 26): S-55.
  • Doğan G. Possible isotretionin- induced keloids in a patient with Behçet’s disease. Clin Exp Dermatol 2006: 31: 535-7.

Behçet hastalığında sistemik isotretinoin tedavisine bağlı hipertofik skarlar: olgu sunumu

Year 2010, Volume: 32 Issue: 1, 137 - 138, 11.03.2010

Elif Öztürk Melih Akyol , Sedat Özçelik

Abstract

Akyol ve ark. [5] daha önce yaygın papülopüstüler lezyonları ve şiddetli artriti olan ve sistemik izotretinoin tedavisine, yan etki görülmeksizin çok iyi yanıt veren bir Behçet hastalığı olgusu bildirmişlerdi. Bununla birlikte Doğan ve ark. [6] tarafından bildirilen başka bir Behçet’li olguda ise sistemik izotretinoin tedavisi ile keloid gelişmiştir

References

  • Bauer EA. Seltzer JL. Eisen AZ. Inhibition of collagen degradative enzymes by retinoic acid in vitro. J Am Acad Dermatol 1982: 6: 603-7.
  • Bernestein LJ, Geronemus RG. Keloid formation with the 585-nm pulsed dye laser during isotretionin treatment. Arch Dermatol 1997: 133: 111-2.
  • Adam B. Calikoglu E. Serum interleukin-6. procalcitonin and C-reactive protein levels in subjects with active Behçet’s disease. J Eur Acad Dermatol Venereol 2004: 18: 318-20.
  • Xue H. McCauley RL. Zhang W. Elavated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000; 89: 74-7.
  • Akyol M, Doğan S, Kaptanoğlu E, Özçelik S. Systemic isotretinoin in the treatment of a Behçet’s patient with arthritic symptoms and acne lesions. Clin Exp Rheumatol 2002; 20(4 Suppl 26): S-55.
  • Doğan G. Possible isotretionin- induced keloids in a patient with Behçet’s disease. Clin Exp Dermatol 2006: 31: 535-7.
There are 6 citations in total.

Details

Primary Language English
Journal Section Letters to the Editor
Authors

Elif Öztürk

Melih Akyol

Sedat Özçelik

Publication Date March 11, 2010
Published in Issue Year 2010 Volume: 32 Issue: 1

Cite

AMA Öztürk E, Akyol M, Özçelik S. Behçet hastalığında sistemik isotretinoin tedavisine bağlı hipertofik skarlar: olgu sunumu. CMJ. March 2010;32(1):137-138.